Buy or sell Grail stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Grail Stock

Blood-sampling device

Founded

2012

Notable Investors

Sequoia Capital China

Headquarters

Menlo Park CA, US

Total Funding

$1.9B

About Grail Stock

Grail develops a pan-cancer screening test designed to detect cancer early. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. Jeffrey Huber and Sjuul van den Eertwegh founded Grail in 2016, with its headquarters in Menlo Park in California.

Investors

6 Dimensions Capital

Grail

Ally Bridge Group

Grail

Blue Pool Capital

Grail, Rent the Runway

Hillhouse Capital Group

Grail, Omio

HuangPu River Capital

Grail

Sequoia Capital China

Toutiao, Grail, DataVisor

Funding History

January 2016$85.0M
November 2017$1.2B
May 2018$300M
November 2019$250M

Management

Chief Executive Officer

Hans Bishop

Chief Operating Officer & Chief Financial Officer

Matthew Young

Chief Scientific Officer

Alex Aravanis

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Grail or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo